The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions.If you have any queries about the SPCs on our website then please e-mail vetinfo@hpra.ie


Kelevo 800 µg tablets for dogs



LIVISTO Int'l, S.L.VPA10425/018/003

Main Information

Trade NameKelevo 800 µg tablets for dogs
Active SubstancesLevothyroxine sodium
Dosage FormTablet
Licence HolderLIVISTO Int'l, S.L.
Licence NumberVPA10425/018/003

Group Information

ATC CodeQH03AA01 levothyroxine sodium
Therapeutic ClassHormone
SpeciesDogs

Status

License statusAuthorised
Licence Issued11/06/2021
Legal StatusPOM: Prescription Only Medicine as defined in relevant national legislation

Documents

Summary of Product Characteristics *PDF Version
Package LeafletNo document available
Public Assessment ReportNo document available
VariationsPDF Version

* The PDF document, together with the national-specific product information on this page, constitute the authorised SPC
« Back